Science-led biopharmaceutical company transforming healthcare
Transform cancer treatment with targeted therapies; Improve cardiovascular health through innovative solutions; Enhance respiratory care with advanced medications; Develop precision medicine for personalized treatment; Conduct clinical trials for new therapies
Pledged $50 billion for US growth; 196 projects in their pipeline; Notable investment in Virginia manufacturing facility